|
| Press Releases |
|
 |
|
| Friday, July 9, 2021 |
|
|
Avance Clinical Congratulates Client Tetherex Pharmaceuticals on Initiation of Dosing in a Phase 1 Clinical Study Using a Novel Single-Cycle Adenovirus Vaccine Strategy in Australia |
| The largest Australian full-service CRO for international biotechs and Frost & Sullivan Asia-Pacific CRO Market Leadership Award winner Avance Clinical today congratulated client Tetherex Pharmaceuticals on first patient dosing for its Phase 1 vaccine clinical trial. more info >> |
|
| Tuesday, June 29, 2021 |
|
|
アバンセ・クリニカル、APACの成長をサポートするためにアジアのバイオテック専門家の任命を発表 |
| 国際的なバイオテクノロジー企業を対象としたオーストラリアの大手CROであり、フロスト＆サリバン社のアジア太平洋地域CROマーケット・リーダーシップ・アワードを受賞したアバンセ・クリニカルは本日、アジア太平洋地域の専門家であるアンディ・フーをアジア太平洋地域のビジネス・ディベロップメント・マネージャーに任命し、同地域で増加するバイオテクノロジーの臨床試験需要をサポートすることを発表しました。 more info >> |
|
| Monday, June 28, 2021 |
|
|
아방스 클리니컬, 아시아 태평양 지역 성장 가속화 위해 아시아 바이오테크 전문가 영입 |
| 글로벌 바이오테크 시장의 전도유망한 호주 임상수탁기관 (CRO)이자 프로스트&설리번 아시아-태평양 CRO 마켓 리더십 어워드 수상에 빛나는 아방스 클리니컬은 아시아 태평양 지역에서의 증가하는 바이오테크 임상 실험 수요를 뒷받침하기 위해 해당 지역을 담당할 전문가로 앤디 후(Andy Hu) 아-태 지역 사업 개발 상무를 영입했다고 오늘 발표했다. more info >> |
|
|
Avance Clinical任命亞洲生物科技公司專家協助其亞太地區業務的增長 |
| 澳大利亞領先的國際生物技術CRO 和Frost & Sullivan 亞太CRO 市場領導獎獲得者Avance Clinical 今天宣布任命亞太地區專家Andy Hu 為亞太地區業務發展經理，以支持該地區日益增長的生物技術臨床試驗需求。 more info >> |
|
|
Avance Clinical任命亚洲生物科技公司专家协助其亚太地区业务的增长 |
| 澳大利亚领先的国际生物技术 CRO 和 Frost & Sullivan 亚太 CRO 市场领导奖获得者 Avance Clinical 今天宣布任命亚太地区专家 Andy Hu 为亚太地区业务发展经理，以支持该地区日益增长的生物技术临床试验需求。 more info >> |
|
|
Avance Clinical Appoints Asia Biotech Specialist to Support APAC Growth |
| The leading Australian CRO for international biotechs and Frost & Sullivan Asia-Pacific CRO Market Leadership Award recipient Avance Clinical today announced the appointment of APAC expert Andy Hu as Business Development Manager APAC to support increasing biotech clinical trial demand from the region. more info >> |
|
| Friday, June 4, 2021 |
|
|
Avance Clinical's USA Biotech Survey Finds 21% Not Aware Australian Clinical Data is Accepted by the FDA and Other Major Regulatory Authorities |
| The leading Australian CRO for biotechs and Frost & Sullivan Asia-Pacific CRO Market Leadership Award recipient Avance Clinical announced the results of their Australian Clinical Trials Knowledge Survey with Endpoints News as part of their presence at BIO Digital 2021. more info >> |
|
| Friday, May 28, 2021 |
|
|
아방스 클리니컬, 바이오 코리아 2021에서 업계 조사 결과 발표 |
| 호주의 바이오테크 임상수탁기관(CRO) 선두주자이자 프로스트&설리번(Frost & Sullivan)이 수여하는 아시아-태평양 CRO 마켓 리더십 어워드(Asia-Pacific CRO Market Leadership Award)를 수상한 바 있는 아방스 클리니컬은 자체 설문 조사를 수행한 결과 호주 내 임상2상 연구를 위한 CRO 선정에 있어서 가장 중요한 기준으로 데이터 품질이 꼽혔다며 최근의 조사 결과를 공유했다. more info >> |
|
| Thursday, May 27, 2021 |
|
|
Avance Clinical Releases Industry Survey Results at BIO Korea 2021 |
| The leading Australian CRO for biotechs and Frost & Sullivan Asia-Pacific CRO Market Leadership Award recipient Avance Clinical shared results of a recent industry survey conducted by the company that found data quality to be the most important criteria for selecting a CRO for Phase ll studies in Australia. more info >> |
|
| Thursday, May 6, 2021 |
|
|
Avance Clinical社、遺伝子技術を用いた臨床試験サービスを拡大 174億ドルの市場需要に対応 |
| オーストラリアのバイオテック企業向けCROのリーディングカンパニーであり、フロスト＆サリバン社の アジア太平洋CROマーケットリーダーシップアワードを受賞したAvance Clinical社は、2023年までに174億ドルに達すると予測される世界的な需要の増加に対応するため、遺伝子技術を用いた臨床試験サービスを拡充しました。 more info >> |
|
|
|
|
|
|
|
|
|
| Latest Press Releases |
|
侨雄国际宣布委任段玉聪院士为人工智能实验室首席科学家
Nov 5, 2024 19:25 HKT/SGT
|
|
|
华邦科技正式更名为「亨利加集团有限公司」
Nov 5, 2024 19:15 HKT/SGT
|
|
|
華邦科技正式更名為「亨利加集團有限公司」
Nov 5, 2024 19:11 HKT/SGT
|
|
|
僑雄國際宣佈委任段玉聰院士為人工智能實驗室首席科學家
Nov 5, 2024 19:00 HKT/SGT
|
|
|
ALMAC to open mid-November
Nov 5, 2024 18:46 HKT/SGT
|
|
|
Champion REIT Recognised as 'GRESB Global Listed Sector Leader'
Nov 5, 2024 18:11 HKT/SGT
|
|
|
富士通、東証の株式売買システム「arrowhead4.0」を運用開始
Nov 5, 2024 18:00: JST
|
|
|
冠君产业信托获GRESB评为「全球业界领导者（上市企业）」
Nov 5, 2024 17:41 HKT/SGT
|
|
|
冠君產業信託獲GRESB評為「全球業界領導者（上市企業）」
Nov 5, 2024 17:14 HKT/SGT
|
|
|
Victory and world title for TOYOTA GAZOO Racing
Nov 5, 2024 17:59 JST
|
|
|
Tokyo Stock Exchange and Fujitsu announce renewal of cash equity trading system 'arrowhead4.0'
Nov 5, 2024 17:13 JST
|
|
|
Mitsubishi Heavy Industries Continues Order Intake, Revenue, and Profit Growth in Strong First Half, Raises Full-Year Order Intake Guidance
Nov 5, 2024 14:37 JST
|
|
|
Interroyal Engineering PCL (SET: IROYAL) Posts Strong Showing on First Trading Day
Nov 5, 2024 13:00 HKT/SGT
|
|
|
華泰證券入圍「跨境理財通」試點 服務大灣區多元化財富管理需求
Nov 5, 2024 11:50 HKT/SGT
|
|
|
Eisai's Corporate Venture Capital Subsidiary, Eisai Innovation, Inc., Selected for AMED's 'Strengthening Program for Pharmaceutical Startup Ecosystem"
Nov 5, 2024 11:35 JST
|
|
|
|
|
More News >> |
|
|
|
|
|
